Philip Cortes
LightNews LightNews
philipcortes.bsky.social
Philip Cortes
@philipcortes.bsky.social
61 followers 410 following 6 posts
Product Craftsman. Tinkering on something in AI + Healthcare: Atlas, the next frontier of human wellness. Ex: @wealthfront, @bloomberg, @wharton.

Join our iOS Atlas Alpha Testing Group: https://testflight.apple.com/join/Lh22u37h
Posts Replies Media Videos
Reposted by Philip Cortes
mcuban.bsky.social
Hello Less Hateful World
November 12, 2024 at 1:37 PM
philipcortes.bsky.social
Bluesky feels like this magical place where all the leading scientific and medical minds of the universe have agreed to finally congregate without any of the noise.

Really happy I discovered this place. Thank you all for jumpstarting it!
November 12, 2024 at 5:23 PM
Reposted by Philip Cortes
dingdingpeng.the100.ci
OR, 0.57; 95% CI: 0.32-1.04 🥲

I’m so surprised that there aren’t more and bigger studies on this. I understand that collecting data is expensive etc etc. BUT I think the public health implications would be huge. If their effects are even just close to an OR = 0.5, just put them everywhere pls 🙏
scientificdiscovery.dev Saloni @scientificdiscovery.dev · Nov 12
New RCT detects no impact of HEPA filters on respiratory infections in people in residential care homes.

But unfortunately, the design isn't very informative overall.
jamanetwork.com/journals/jam...
Screenshot of introduction: Design, Setting, and Participants This randomized clinical trial used a multicenter, double-blind, 2-period, 2-treatment crossover design for 6 months from April 7 to October 26, 2023, in 3 RACFs with a bed capacity of 50 to 100 in New South Wales, Australia. The purposive sampling approach included permanent residents in private rooms in the enrolled RACFs. Data collection was performed every 2 weeks and required no additional follow-up beyond the final data collection on October 31, 2023. Intervention An air purifier containing a HEPA-14 filter was placed in rooms of participants in the intervention group, and an air purifier without a HEPA-14 filter was placed in rooms of the control participants. The groups crossed over after 3 months. Main Outcomes and Measures The primary outcome was the incidence of ARIs, assessed with logistic mixed-model regression. Results Among 135 participants randomized (70 to the intervention-first group and 65 to the control-first group), 78 (57.8%) were female; mean (SD) age was 85.2 (8.6) years. In the intention-to-treat analysis, the use of air purifiers with HEPA-14 filters did not reduce ARIs compared with the control (OR, 0.57; 95% CI, 0.32-1.04; P = .07). Among the 104 participants who completed the entire study, the intervention reduced ARI incidence from 35.6% (37 participants) in the control group to 24.0% (25 participants) in the intervention group (OR, 0.53; 95% CI, 0.28-1.00; P = .048).
November 12, 2024 at 3:34 PM